Nutraceutical production equipment financing gives supplement, vitamin, and functional-food manufacturers a way to acquire encapsulation machines, tablet presses, blending systems, and packaging lines without draining working capital. Whether you are scaling from a co-manufacturer relationship to your own production floor or upgrading aging equipment to meet cGMP standards, the right financing structure can be the difference between a six-month capital raise and a machine running on your floor next month.
The U.S. dietary supplement market has grown into a roughly $69-$78 billion industry, and demand for private-label and contract manufacturing capacity has never been higher. That growth has created real pressure on nutraceutical companies to add capacity fast, but industrial-grade encapsulators, tablet presses, and coating pans routinely cost anywhere from $40,000 to well over $500,000 per unit. Very few growing supplement brands can pay cash for that kind of equipment without stalling other parts of the business.
In This Article
Nutraceutical production equipment financing is a category of commercial equipment financing designed specifically for companies that manufacture dietary supplements, vitamins, functional foods, protein powders, and other nutraceutical products. It covers the machinery used to blend raw ingredients, form tablets or capsules, coat and polish finished units, and package and label the final product for retail or wholesale distribution.
Instead of paying the full purchase price of a piece of equipment upfront, a business works with a lender to spread the cost over a fixed term, typically two to seven years depending on the equipment's useful life. The equipment itself usually serves as collateral, which allows lenders to offer more competitive terms than an unsecured loan would carry.
This type of financing is not a generic small business loan. Underwriters who specialize in equipment financing understand the resale value of a tablet press or an encapsulation line, the compliance requirements around cGMP-certified production environments, and the cash flow cycles of a nutraceutical brand that may have seasonal spikes around New Year's resolutions, back-to-school immunity products, or holiday wellness bundles.
Key Stat: The U.S. dietary supplements market reached an estimated $69.3 billion in 2024, according to the Nutrition Business Journal, with continued mid-single-digit annual growth projected. Rising demand is pushing more brands to bring production in-house rather than relying solely on third-party co-manufacturers.
Financing production equipment instead of buying it outright preserves options that a supplement manufacturer needs during a growth phase. The advantages go well beyond simply "not paying cash."
Ready to Add Production Capacity?
Get fast, flexible equipment financing from the #1 business lender in the U.S. No obligation, apply in minutes.
Apply Now →The process is more straightforward than most first-time applicants expect. A typical financing timeline runs from application to funding in as little as a few business days for standard requests, though larger or more complex equipment packages can take longer.
Here is the general sequence a nutraceutical manufacturer can expect:
Lenders will typically look at time in business, personal and business credit, and whether the equipment has a strong resale market. Newer nutraceutical brands without years of financials can sometimes still qualify by leaning on the collateral value of the equipment itself, though terms may reflect a shorter track record.
Nutraceutical manufacturing involves a wide range of specialized machinery, and most of it qualifies for equipment financing. The most commonly financed categories include:
Both new and used equipment typically qualify, which matters in this industry since a well-maintained secondary-market tablet press can run for decades with proper servicing.
It is worth noting that equipment financing generally covers the physical machinery itself rather than the facility build-out around it. Cleanroom flooring, dedicated electrical panels, and specialized ventilation ductwork sometimes fall into a gray area depending on the lender, so it pays to ask upfront whether facility improvements tied directly to a piece of equipment can be rolled into the same financing package or need to be handled separately through a working capital product.
By the Numbers
Equipment Financing and the Nutraceutical Industry
$69B+
Size of the U.S. dietary supplement market (2024, Nutrition Business Journal)
8 in 10
U.S. businesses use some form of financing when acquiring equipment
73%
Full approval rate for equipment loan applications nationally
5.5%
Projected 2025 growth rate for the U.S. supplement industry
This type of financing tends to make the most sense for a specific set of business situations rather than every supplement company across the board.
Companies with seasonal or highly variable cash flow, common in the wellness and supplement space around Q1 and Q4, often benefit from equipment financing's fixed payment structure rather than a revenue-based product that fluctuates with sales.
It is also worth considering financing if your business has outgrown a co-packer's minimum order quantities or production scheduling flexibility. Many contract manufacturers prioritize their largest clients first, which can leave smaller or mid-sized supplement brands waiting weeks for a production slot during peak season. Owning your own equipment removes that dependency entirely.
Equipment financing is not the only path to acquiring production machinery. Here is how it stacks up against the other options nutraceutical manufacturers commonly consider.
| Option | Best For | Collateral | Typical Term |
|---|---|---|---|
| Equipment Financing | Purchasing a specific machine (press, encapsulator, packaging line) | The equipment itself | 2-7 years |
| Equipment Leasing | Equipment that may need upgrading before it wears out | Leased asset, often lower down payment | 2-5 years |
| SBA 504 Loan | Large fixed-asset purchases, including real estate plus heavy equipment | Real estate and/or equipment | 10-25 years |
| Unsecured Working Capital | Ingredient purchases, payroll, marketing (not equipment-specific) | None (unsecured) | 3 months-2 years |
| Business Line of Credit | Ongoing flexible access to funds, revolving use | Varies by lender | Revolving, no fixed term |
For most nutraceutical manufacturers, equipment financing wins out over a line of credit or unsecured loan specifically because the collateral value of the machinery lets lenders offer longer terms and often more competitive rates than an unsecured product would carry.
Crestmont Capital works with supplement and nutraceutical manufacturers to structure equipment financing around the realities of the industry, not a one-size-fits-all template. Our equipment financing programs cover new and used production machinery, and our equipment leasing options give growing brands a lower-commitment path to upgrade lines without a large down payment.
For manufacturers whose needs go beyond a single machine, our business line of credit and unsecured working capital loans can supplement equipment financing to cover raw ingredient purchases, third-party lab testing costs, or packaging inventory that ramps up alongside new production capacity.
We have also worked directly with broader industrial and manufacturing businesses navigating similar capital needs. If you are weighing multiple financing paths, our guides on manufacturing business loans and funding a health supplement company cover related financing strategies that many nutraceutical business owners use alongside equipment financing.
Our underwriting team understands that a tablet press or encapsulation line holds real resale value, and we factor that into how we structure approvals, terms, and rates, rather than treating your business like a generic borrower with no industry context.
Let's Talk About Your Production Line
Whether it's a single tablet press or a full packaging line, get financing built around your equipment and your timeline.
Apply Now →The following scenarios illustrate how nutraceutical companies typically approach equipment financing decisions. Names and specific figures are illustrative examples reflecting common industry situations, not individual client case studies.
Scenario 1: The graduating co-packer client. A private-label supplement brand has spent three years using a contract manufacturer to produce its capsule line. As order volume grows past what the co-packer can prioritize on their schedule, the brand finances an automated encapsulation machine and a bottle-filling line to bring production in-house, cutting per-unit costs and controlling its own production calendar.
Scenario 2: The cGMP compliance upgrade. An established vitamin manufacturer's tablet press is nearing the end of its documented validation life. Rather than risk a failed FDA facility inspection, the company finances a replacement press with updated automation and traceability features, spreading the cost over five years instead of pulling cash from reserves earmarked for ingredient purchasing.
Scenario 3: Adding a new product format. A capsule-only supplement brand wants to launch a gummy vitamin line to capture a growing segment of the market. Because gummy production requires entirely different equipment (depositors, cooling tunnels, and enrobing machines), the company uses equipment financing to add the new line without disrupting cash flow for its existing capsule business.
Scenario 4: Seasonal demand planning. A functional-food manufacturer sees a predictable spike in orders every January tied to New Year's resolution demand. Financing a second packaging line ahead of Q4 lets the company build inventory in advance without straining working capital during its highest-cost production months.
Scenario 5: The used-equipment opportunity. A contract manufacturer identifies a well-maintained, refurbished blending system from a liquidating facility at a significant discount to new equipment pricing. Equipment financing on the used unit lets the company capture the discount while preserving cash for the freight, installation, and validation costs that come with any equipment purchase.
Nutraceutical manufacturers moving quickly to add capacity sometimes make avoidable mistakes during the financing process. Watching for these can save real time and money.
Pro Tip: Ask your equipment vendor for a written specification sheet covering power requirements, footprint, and any special ventilation needs before you finalize financing. Facility surprises after equipment arrives are one of the most common causes of installation delays in nutraceutical manufacturing.
Not every commercial lender understands the nutraceutical manufacturing space, and that gap shows up in how they evaluate your application. A generalist lender may struggle to properly value a used tablet press or may not understand why a supplement brand needs cGMP-compliant equipment in the first place.
When evaluating financing partners, look for a few specific signals of industry familiarity. Ask whether they have financed similar equipment before, whether they can move quickly once a vendor quote is in hand, and whether they offer flexibility on structuring around seasonal production cycles. A lender who asks informed questions about batch sizes, fill rates, or validation timelines is more likely to structure a deal that actually fits how your business operates.
It is also worth confirming whether the lender funds directly to the equipment vendor or requires you to pay upfront and seek reimbursement. Direct vendor funding is generally faster and reduces the cash flow strain on your business during the purchase process.
It is a form of commercial equipment financing that allows dietary supplement, vitamin, and functional food manufacturers to acquire production machinery, such as tablet presses, encapsulators, and packaging lines, and pay for it over a fixed term rather than in a single lump sum.
Most production and packaging equipment qualifies, including tablet presses, encapsulation machines, blenders, granulators, coating pans, bottling and packaging lines, labeling equipment, and quality control lab equipment such as HPLC systems.
Yes. Most equipment financing programs cover both new and used equipment, including refurbished tablet presses and encapsulation lines purchased through equipment resellers or liquidation sales.
Standard equipment financing requests can often be approved within a few business days once financials and the equipment quote are submitted. Larger or more complex equipment packages may take longer depending on documentation needs.
Requirements vary by lender, but because the equipment itself serves as collateral, many equipment financing programs are more flexible on credit than unsecured products. A stronger credit profile typically unlocks better rates and terms.
No. Equipment financing is separate from your facility's regulatory certification status. Many companies finance equipment specifically to help them meet or maintain cGMP compliance standards as part of a facility upgrade.
Down payments vary by lender and equipment type, and some programs offer no down payment at all for well-qualified applicants. Others may require 10-20% down depending on the equipment's age and resale value.
It depends on your goals. Financing makes sense if you plan to own the equipment long-term and use it well beyond the payment term. Leasing can make sense if you expect to upgrade equipment more frequently or want a lower upfront commitment.
Newer companies without years of financial history can sometimes qualify, especially since the equipment's resale value supports the loan. Terms for newer businesses may reflect a shorter operating history through rate or down payment adjustments.
With most equipment financing agreements, you own the equipment outright once the final payment is made. Some lease structures include a $1 buyout option, while others may offer a fair-market-value buyout at term end.
Yes. Many lenders will bundle multiple pieces of equipment, such as a tablet press plus a coating pan plus packaging equipment, into a single financing agreement with one combined monthly payment.
Equipment financing is typically structured separately from a revolving line of credit, which means it generally does not reduce your available line of credit the way a large cash withdrawal might. This is one reason many manufacturers use both products together.
Most tangible production and packaging equipment with resale value qualifies. The best way to confirm is to get a formal quote from your equipment vendor and submit it along with your application for a specific determination.
Many nutraceutical brands see demand spikes around January and Q4 holiday wellness bundles. Financing equipment ahead of a seasonal ramp, rather than waiting until demand peaks, gives a manufacturer time to install, validate, and run the equipment before the busiest ordering window arrives.
Both options exist, but an independent commercial lender can often offer more flexibility on terms, faster funding timelines, and the ability to bundle financing across multiple equipment vendors rather than being tied to a single manufacturer's in-house financing arm.
Get Your Production Line Funded
Apply today and see what equipment financing terms your business qualifies for. No obligation.
Apply Now →Nutraceutical production equipment financing gives supplement and functional-food manufacturers a practical way to add capacity, meet compliance requirements, and launch new product formats without draining the working capital needed to run the rest of the business. With the U.S. dietary supplement market continuing to grow, brands that can move quickly on production capacity have a real advantage over those waiting to save up cash reserves. Whether you need a single tablet press or a full packaging line, structuring the right financing now can put new capacity on your production floor in weeks rather than months.
Disclaimer: The information provided in this article is for general educational purposes only and is not financial, legal, or tax advice. Funding terms, qualifications, and product availability may vary and are subject to change without notice. Crestmont Capital does not guarantee approval, rates, or specific outcomes. For personalized information about your business funding options, contact our team directly.